| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |